Benchmark Holdings Plc

Report Publication Announcement • Apr 16, 2025

National Storage Mechanism | Additional information

RNS Number : 3022F

Benchmark Holdings PLC

16 April 2025

16 April 2025

Benchmark Holdings plc

Update on Strategy for the Continuing Business and Return of Capital

Further to the announcement on 31 March 2025, Benchmark Holdings plc ("Benchmark", the "Group", or the "Company"), announces that details on the strategy for the continuing business and return of capital are now expected to be provided during May. 

The Company is pleased to have completed the redemption of its Green Bond as announced on 15 April, and confirms that it has recently repaid the RCF making the Group debt free. The Company has also made substantial progress in streamlining the Group's corporate structure following completion of the sale of Genetics, rightsizing the organisation for the next phase.

Enquiries:

For further information please contact:

Benchmark Holdings plc			Tel: 0114 240 9939
Ivonne Cantu, Investor Relations
Deutsche Numis (Broker and NOMAD to Benchmark)			Tel: 020 7260 1000
Freddie Barnfield, Duncan Monteith, Sher Shah
MHP Group (Press Enquiries)			Tel: +44 7831 406117
Katie Hunt, Reg Hoare			[email protected]

ABOUT BENCHMARK

Benchmark is a market leading aquaculture biotechnology company.  Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in advanced nutrition and health which improve yield, growth and animal health and welfare. Through a global footprint and a broad portfolio of products and solutions, Benchmark addresses many of the major aquaculture species - salmon, shrimp, sea bass and sea bream in all the major aquaculture regions around the world.  Find out more at  www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDGPUBACUPAUBQ